“…Computational analysis also identified FGD5-AS1 as a key lncRNA for acute myocardial infarction. Other evidence of the regulatory functions of FGD5-AS1 came from studies of cancers such as colorectal cancer ( Li et al, 2019 ), non-small lung cancer ( Fan et al, 2020 ; Fu et al, 2020 ), gastric cancer ( Gao et al, 2020a ), melanoma ( Gao et al, 2020b ), oral cancer ( Liu et al, 2020 ), glioblastoma ( Su et al, 2020 ), glioma ( Lin et al, 2020 ; Zhao et al, 2020 ), renal cell carcinoma ( Yang et al, 2020 ), and hepatocellular carcinoma ( Zhang and Lou, 2020 ). A variety of related miRNAs (e.g., miR-223, miR-140-5p, miR-383, miR-153, miR-103a-3p, miR-129-5p, and miR-5590-3p) were also reported as interacting with FGD5-AS1 in the above-mentioned works.…”